\documentclass[10pt]{article}

\usepackage{fullpage}
\usepackage{setspace}
\usepackage{parskip}
\usepackage{titlesec}
\usepackage[section]{placeins}
\usepackage{xcolor}
\usepackage{breakcites}
\usepackage{lineno}
\usepackage{hyphenat}





\PassOptionsToPackage{hyphens}{url}
\usepackage[colorlinks = true,
            linkcolor = blue,
            urlcolor  = blue,
            citecolor = blue,
            anchorcolor = blue]{hyperref}
\usepackage{etoolbox}
\makeatletter
\patchcmd\@combinedblfloats{\box\@outputbox}{\unvbox\@outputbox}{}{%
  \errmessage{\noexpand\@combinedblfloats could not be patched}%
}%
\makeatother


\usepackage{natbib}




\renewenvironment{abstract}
  {{\bfseries\noindent{\abstractname}\par\nobreak}\footnotesize}
  {\bigskip}

\titlespacing{\section}{0pt}{*3}{*1}
\titlespacing{\subsection}{0pt}{*2}{*0.5}
\titlespacing{\subsubsection}{0pt}{*1.5}{0pt}


\usepackage{authblk}


\usepackage{graphicx}
\usepackage[space]{grffile}
\usepackage{latexsym}
\usepackage{textcomp}
\usepackage{longtable}
\usepackage{tabulary}
\usepackage{booktabs,array,multirow}
\usepackage{amsfonts,amsmath,amssymb}
\providecommand\citet{\cite}
\providecommand\citep{\cite}
\providecommand\citealt{\cite}
% You can conditionalize code for latexml or normal latex using this.
\newif\iflatexml\latexmlfalse
\providecommand{\tightlist}{\setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}%

\AtBeginDocument{\DeclareGraphicsExtensions{.pdf,.PDF,.eps,.EPS,.png,.PNG,.tif,.TIF,.jpg,.JPG,.jpeg,.JPEG}}

\usepackage[utf8]{inputenc}
\usepackage[english]{babel}



\usepackage{float}








\begin{document}

\title{Re-emergence of influenza Virus Circulation during 2020 in parts of
Tropical Asia: Implications for Other Countries}



\author[1]{Joshua Mott}%
\author[1]{Alicia Fry}%
\author[1]{Rebecca Garten}%
\author[1]{David Wentworth}%
\author[1]{Sonja Olsen}%
\affil[1]{CDC}%


\vspace{-1em}



  
  \date{May 21, 2024}


\begingroup
\let\center\flushleft
\let\endcenter\endflushleft
\maketitle
\endgroup





\selectlanguage{english}
\begin{abstract}
Global influenza virus circulation declined and has been below
traditional seasonal levels during the COVID-19 pandemic.1-3 We reviewed
WHO influenza surveillance outputs from May 1-December 31, 2020
(epidemiologic weeks 18-53) from tropical Asian countries. For each
country we report influenza surveillance specimens tested, and the
percentage positive for influenza, by type and subtype. We compared
current data to historical data from 2015-2019 in order to place the
current season in historical context. Twelve included countries tested
17,407 surveillance specimens, with 592 (3.4\%) testing positive for
influenza viruses. From April 27-July 26, 2020 (epidemiologic weeks
18-30), specimens tested decreased from an average of 14,102 per year in
2015-2019 to 3,969 (71.9\% decrease) and influenza positivity from 22\%
to \textless{}1\%. During weeks 31-53, specimens tested decreased from
an average of 24,782 per year in 2015-2019 to 13,438 (45.8\% decrease)
and influenza positivity from 18\% to 4\%. In six countries that
maintained testing of surveillance specimens for \textgreater{}90\% of
weeks, influenza circulation was unseasonably low, or absent, during
weeks 18-30, 2020. However, during weeks 31-53, the percentage of
surveillance specimens testing positive for influenza approached or
reached positivity rates of 2015-2019 in Bangladesh and Cambodia; and
increased but remained lower than historical positivity in Lao PDR and
Viet Nam. The data presented here are a reminder that the low levels of
influenza circulation in the northern hemisphere in summer 2020 may not
necessarily persist into the upcoming influenza season, and influenza
surveillance and prevention strategies should continue as planned and
not be delayed.%
\end{abstract}%



\sloppy


\textbf{Re-emergence of influenza Virus Circulation during 2020 in parts
of Tropical Asia: Implications for Other Countries}

Joshua A. Mott\textsuperscript{1} PhD, Alicia M.
Fry\textsuperscript{2}MD, Rebecca Kondor\textsuperscript{2}PhD, David E.
Wentworth\textsuperscript{2}PhD, Sonja J. Olsen PhD\textsuperscript{2}

\textsuperscript{1} Influenza Division, Centers for Disease Control and
Prevention Regional Influenza Program, Bangkok, Thailand

\textsuperscript{2} Influenza Division, Centers for Disease Control and
Prevention, Atlanta, Georgia

\textbf{Word count:} 782

\textbf{Corresponding author:}

Joshua A. Mott, PhD, Director, CDC Regional Influenza Program, Bangkok,
Thailand

DDC 7 Building, 4th Floor, Ministry of Public Health, Soi 4, Tiwanon Rd,
Nonthaburi 11000,

Thailand

Email: jmott@cdc.gov

Mobile: +66 (0) 84 874-2167

\textbf{Key Words:} Influenza A virus, H3N2 subtype; sentinel
surveillance; Southeastern Asia; tropical climate

Global influenza virus circulation declined and has been below
traditional seasonal levels during the COVID-19
pandemic.\textsuperscript{1-3} After learning of increased influenza
virus circulation in some tropical Asian countries, we reviewed current
surveillance data to better ascertain risk for an influenza resurgence
during the 2020-2021 Northern Hemisphere influenza season and subsequent
seasons during the COVID-19 pandemic.

\textbf{Methods}

As COVID-19 began to circulate more widely in March and April, 2020, and
influenza circulation typically increases during the second half of the
calendar year in tropical Asian countries,\textsuperscript{4} we
reviewed WHO influenza surveillance outputs from May 1-December 31, 2020
(epidemiologic weeks 18-53) from tropical Asian countries that have land
mass between the Tropics of Cancer and Capricorn.\textsuperscript{5} We
excluded China and Australia, as most areas of those countries have
influenza seasons that generally follow temperate rather than tropical
seasonal patterns. We then identified countries that tested surveillance
specimens for influenza viruses during at least 50\% of the 36 weeks
(19/36 weeks) between May 1 and December 31, 2020. For each country we
report influenza surveillance specimens tested, and the percentage
positive for influenza, by type and subtype. We compared current data to
historical data from 2015-2019 in order to place the current season in
historical context.

\textbf{Results}

Of 17 countries, 12 (70\%) reported testing influenza surveillance
specimens for more than half of the weeks during May 1 -- December 31,
2020 (Table 1). These 12 countries tested 17,407 surveillance specimens,
with 592 (3.4\%) testing positive for influenza viruses. Influenza
A(H3N2) viruses were detected in 573/592 (97\%) influenza positive
specimens. From April 27-July 26, 2020 (epidemiologic weeks 18-30),
specimens tested decreased from an average of 14,102 per year in
2015-2019 to 3,969 (71.9\% decrease) and influenza positivity from 22\%
to \emph{\textless{}} 1\%. During weeks 31-53, specimens tested
decreased from an average of 24,782 per year in 2015-2019 to 13,438
(45.8\% decrease) and influenza positivity from 18\% to 4\%.

Of these 12 countries, six (Bangladesh, Kingdom of Cambodia, Lao PDR,
New Caledonia, Singapore, and Viet Nam) maintained testing of
surveillance specimens for \textgreater{}90\% of weeks. In these
countries we observed considerable variability in influenza circulation.
In each of these six countries, influenza circulation was unseasonably
low, or absent, during weeks 18-30, 2020. However, during weeks 31-53,
the percentage of surveillance specimens testing positive for influenza
approached or reached positivity rates of 2015-2019 in Bangladesh and
Cambodia; and increased but remained lower than historical positivity in
Lao PDR and Viet Nam. No influenza viruses were reported by New
Caledonia and Singapore.

\textbf{Discussion}

Many countries in tropical Asia are struggling to conduct influenza
surveillance in 2020, likely due to disruptions from the COVID-19
pandemic. However, unlike the observation in the Southern
Hemisphere\textsuperscript{1,6,7} influenza has not disappeared from
circulation, and some countries experienced a delayed resurgence of
community circulation of influenza viruses. The heterogeneity in the
magnitude of the influenza activity across countries in tropical Asia is
noteworthy and likely due to multiple factors, including surveillance
artefact, degree of travel restrictions, and adherence to COVID-19
interventions. Although data from Africa are sparse, a similar pattern
may be emerging.\textsuperscript{5} This has important implications for
the 2020-2021 Northern Hemisphere influenza season, and for future
influenza vaccine strain selection.

First, it is critical that persons recommended to receive influenza
vaccinations get vaccinated. The COVID-19 pandemic is disproportionately
impacting older persons, those with underlying chronic conditions, and
other traditionally underserved populations,\textsuperscript{8,9} many
of whom are also at increased risk of severe complications of influenza.
Influenza vaccination could prevent unnecessary added morbidity and
mortality in these target groups and may prevent health care facilities
from being overwhelmed by persons concerned that influenza-associated
respiratory symptoms may represent COVID-19 illness.

Second, maintaining surveillance and outbreak response is essential to
track the geographic spread and obtain viruses so vaccines remain
optimized to circulating influenza viruses. At the WHO Collaborating
Center for Reference and Research on Influenza at CDC Atlanta, global
surveillance submitted 583 influenza viruses to CDC between March 1 and
September 30, 2020, a 69\% decrease from an average of 1,908 viruses
during the same months in the years 2015-2019. Furthermore, the limited
data from tropical Asia suggest that genetically divergent influenza
A(H3N2) viruses are currently in circulation. In Cambodia, officials
investigated outbreaks of influenza A(H3N2) viruses in semi-closed
settings in August-October 2020.\textsuperscript{10} These viruses and
some from Bangladesh, belong to a different genetic clade,
3C.2a1b+T131K, than the currently recommended 2020-2021 Northern
Hemisphere influenza vaccine virus, A/Hong Kong/267/2019, which comes
from genetic clade 3C.2a1b+135K+137F.\textsuperscript{11}

The data presented here are a reminder that the low levels of influenza
circulation seen in the northern hemisphere in summer 2020 may not
necessarily persist into the upcoming influenza season, and influenza
surveillance and prevention strategies should continue as planned and
not be delayed.

\textbf{Disclaimer}

The findings and conclusions in this report are those of the authors and
do not necessarily represent the official of the Centers for Disease
Control and Prevention.

\textbf{References}

1. Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased Influenza
Activity During the COVID-19 Pandemic - United States, Australia, Chile,
and South Africa, 2020. \emph{MMWR Morb Mortal Wkly
Rep.}2020;69(37):1305-1309.

2. Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased Influenza Incidence
under COVID-19 Control Measures, Singapore. \emph{Emerg Infect
Dis.}2020;26(8):1933-1935.

3. WHO. FluNet Summary 26 October 2020. 2020;
https://www.who.int/influenza/surveillance\_monitoring/updates/latest\_update\_GIP\_surveillance/en/.
Accessed November 2, 2020.

4. Hirve S, Newman LP, Paget J, et al. Influenza Seasonality in the
Tropics and Subtropics - When to Vaccinate? \emph{PLoS
One.}2016;11(4):e0153003.

5. WHO. Influenza Surveillance Outputs. 2021;
https://www.who.int/influenza/resources/charts/en/ Accessed January 12,
2021.

6. Huang QS, Wood T, Jelley L, et al. Impact of the COVID-19
nonpharmaceutical interventions on influenza and other respiratory viral
infections in New Zealand. \emph{medRxiv.} 2020.

7. Sullivan SG, Carlson S, Cheng AC, et al. Where has all the influenza
gone? The impact of COVID-19 on the circulation of influenza and other
respiratory viruses, Australia, March to September 2020. \emph{Euro
Surveill.} 2020;25(47).

8. Grohskopf LA, Liburd LC, Redfield RR. Addressing Influenza
Vaccination Disparities During the COVID-19 Pandemic. \emph{JAMA.} 2020.

9. Zheng Z, Peng F, Xu B, et al. Risk factors of critical \& mortal
COVID-19 cases: A systematic literature review and meta-analysis.\emph{J
Infect.} 2020;81(2):e16-e25.

10. Sovann LY, Sar B, Kab V, et al. An influenza A (H3N2) virus outbreak
in the Kingdom of Cambodia during the COVID-19 pandemic of
2020.\emph{Int J Infect Dis.} 2020;103:352-357.

11. WHO. Recommended composition of influenza virus vaccines for use in
the 2020 - 2021 northern hemisphere influenza season. 2020;
https://www.who.int/influenza/vaccines/virus/recommendations/2020-21\_north/en/.
Accessed October 30, 2020.

\textbf{Table 1: Laboratory-confirmed influenza reported to WHO/FluNet
among tropical Asian countries that maintained influenza surveillance
during 2020: Epidemiologic weeks 18-53, 2015-2020}\selectlanguage{english}
\begin{longtable}[]{@{}lllllllllll@{}}
\toprule
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Country}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2020}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2015-2019}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Influenza virus circulation,} \textbf{2015-2019}\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Most recent week of report}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Most recent week of influenza detection}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Number of weeks with specimens processed}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
(\% of 36 weeks)\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Specimens tested during epidemiologic weeks 18-53}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Influenza detected during weeks 18-53*}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Epidemiologic weeks during weeks 18-53, with influenza virus
detections}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Influenza surveillance specimens tested and number positive in
weeks 18-30}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Influenza surveillance specimens tested and number positive in
weeks 31-53}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Influenza surveillance specimens tested and number positive in
weeks 18-30}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{Influenza surveillance specimens tested and number positive in
weeks 31-53}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Bangladesh}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
52\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
45\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
35 (97\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
3,552\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
208 A(H3)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
25, 32-45\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1/745 (0.1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
207/2,807 (12\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
3,420/10,591 (32\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,151/13,954 (8\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Cambodia}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
52\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
46\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
35 (97\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
737\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
108 A(H3)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
27,29, 31-46\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
3/285 (1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
105/452 (23\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
463/1,663 (28\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
819/2,957 (28\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{India}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
51\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
51\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
30 (83\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2,176\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
13 A(H3)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
41-45, 47, 50-51\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/574 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
13/1,602 (1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,825/12,889 (14\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
5,013/33,936 (15\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Indonesia}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
41\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
36\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
22 (61\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
131\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
3 A(H3)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
20, 34, 36\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1/66 (2\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2/65 (3\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
769/3,784 (20\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,205/5,958 (20\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Lao PDR}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
52\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
51\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
34 (94\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2,205\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
116 A(H3) 1 A(H1)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
32, 36, 38-51\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/390 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
117/1,815 (6\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
447/6,459 (7\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2,103/10,405 (20\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Malaysia}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
50\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
34\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
31 (86\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,607\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1 A(H1)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
34\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/563 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1/1,044 (0.1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
653/5,790 (11\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,042/8,239 (13\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Maldives}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
53\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
20 (56\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
138\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/47 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/91 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
419/1,334 (31\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
191/1,332 (14\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{New Caledonia}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
53\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
36 (100\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
462\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/236 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/226 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
489/2,098 (23\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
514/2,495 (21\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Singapore}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
53\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
36 (100\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,497\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
n/a\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/398 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/1,099 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,951/4,217 (46\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,536/4,645 (33\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Thailand}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
43\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
43\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
26 (72\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
741\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
3 A(H1) 1 B\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
36,37,43\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/252 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
4/489 (1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,033/3,939 (26\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2,628/8,231 (32\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Timor-Leste}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
47\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
46\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
21 (58\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
2,772\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
14 A(H3) 12 A(H1) 1 B\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
30, 32-33, 38-42, 44, 46\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
8/49 (16\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
19/2,723 (1\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
99/293 (34\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
4/347 (1\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Viet Nam}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
50\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
50\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
33 (92\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,389\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
111 A(H3\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
40-50\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
0/364 (0\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
111/1,025 (11\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
848/3,349 (25\%)\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
1,276/6,627 (19\%)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{Total}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{17,407}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{573 A(H3)} \textbf{17 A(H1)} \textbf{2 B}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{13/3,969 (0.3\%)}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{579/13,438} \textbf{(4\%)}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{12,516/56,406 (22\%)}\strut
\end{minipage} & \begin{minipage}[t]{0.09\columnwidth}\raggedright\strut
\textbf{17,482/99,126 (18\%)}\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\textbf{* The years 2015 and 2020 included 53 epidemic weeks. The years
2016-2019 included 52 epidemic weeks.}\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea
(0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report
over 50\% of weeks with influenza specimens processed to meet inclusion
criteria (data last accessed on January 15, 2021).\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage} & \begin{minipage}[t]{0.07\columnwidth}\raggedright\strut
\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

\selectlanguage{english}
\FloatBarrier
\end{document}

